FDA Warning Letter Lessons: Sterility Assurance, Investigations & Visible Particulate Control
A recent FDA Warning Letter to Fresenius Kabi USA highlights significant GMP lessons for sterile manufacturers involving investigation quality, media fills, aseptic practices, visible particulate control, CAPA effectiveness, facility design, and Quality Unit oversight.
Read Article →